Shopify (TSE:SHO – Get Free Report) was downgraded by equities research analysts at BNP Paribas from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.
Other equities research analysts have also issued reports about the stock. Phillip Securities lowered shares of Shopify from a “strong-buy” rating to a “moderate buy” rating in a report on Monday, February 17th. Benchmark upgraded Shopify from a “hold” rating to a “strong-buy” rating in a report on Monday, February 10th. New Street Research upgraded Shopify to a “hold” rating in a report on Friday, January 10th. Finally, Wedbush upgraded Shopify from a “hold” rating to a “strong-buy” rating in a report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating and eight have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy”.
Read Our Latest Research Report on SHO
Shopify Price Performance
About Shopify
ICC Labs Inc is a medicinal and recreational cannabis producer based in South America. The firm primarily producing, researching and marketing cannabis for medical and recreational uses, and hemp-based products. The company’s operations are organized into two operating segments, Recreational segment and Cannabinoids Extraction segment.
Further Reading
- Five stocks we like better than Shopify
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Mid-Cap Medical Stocks Outperforming the Market
- 3 Best Fintech Stocks for a Portfolio Boost
- The Top-Ranked Insider Buys From April by Market Cap
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Shopify Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shopify and related companies with MarketBeat.com's FREE daily email newsletter.